"Our belief is that any victim of heart attack or stroke anywhere in
the world should have access to therapies that will help them
enjoy a better post-incident quality of life"
Saving hearts and minds Read More

Novel Drug Candidates

Infensa has a unique portfolio of peptide drugs that protect neurons and heart muscle cells from ischemic injury

Protection of the Brain

Infensa drugs protect the brain from stroke-induced injury

Protection of the Heart

Infensa drugs protect the heart from injury suffered during a heart attack

Game-Changing Therapies

Infensa will develop game-changing therapies for cardiovascular disorders that kill 15 million people every year

An overview of the opportunity

  • First-in-class drugs with addressable worldwide market of tens of millions of patients per year
  • Ability of a single drug class to address multiple diseases enables staged clinical development with continuous value creation
  • Other potential indications: traumatic head injury, hypoxic brain injury (cerebral palsy), retinal artery thrombosis, kidney artery thrombosis, cardiac and brain surgery, endarterectomy, heart valve replacement
  • Key asset protected by patents granted globally
  • Outstanding executive team with more than a century combined experience in the biotech sector